Thursday, September 30, 2021

Twin Cities patients must travel for promising COVID treatment

A persistent lack of appointment slots at health systems across the metro is forcing patients to drive far from the Twin Cities to receive a promising treatment for COVID-19. Infusions of monoclonal antibodies, an outpatient treatment for patients within 10 days of first symptoms, became available in Minnesota during late 2020. From the start, health care providers in the seven-county metro area have provided a disproportionately small share of the statewide total — less than 10% of the doses administered, according to the Minnesota Department of Health.

No comments:

Post a Comment